Indicators of coronary angiography in patients with acute coronary syndrome and atrial fibrillation

Main Article Content

V. Y. Tseluyko
F Ben Salem
N. A. Lopina


The aim – to study the features of coronary artery (CA) deficiency (according to the results of selective coronary angiography) in patients with acute coronary syndrome (ACS) and atrial fibrillation (AF).
Materials and methods. 125 patients who were hospitalized with ACS at the center of percutaneous coronary interventions during four years (2015–2018) were examined. 65 of them had AF. The criterion for inclusion in the study was the presence of ACS; exclusion criteria were the presence of severe concomitant diseases (active oncological processes, chronic renal failure grade IV, etc.), heart disease, refusal of the patient to participate in the study. The patients were divided into groups according to the presence of AF. Group 1 included patients with AF. Those of them who had the first AF onset during the hospitalization with ACS constituted subgroup 1a (n=41). Patients in whom AF was observed prior to the development of ACS composed subgroups 1b (n=24). Group 2 included patients without AF in anamnesis and during hospitalization (n=60).
Results and discussion. The presence of AF in the development of ACS is associated with widespread atherosclerotic damage to CA, a multicentric lesion, statistically significantly greater than the average number of plaques per patient (2.87±0.46 vs. 2.31±0.34; p=0.00001), greater average number of affected segments per patient (2.78±0.42 vs. 2.43±0.37; p=0.0015), higher average number of hemodynamically significant stenoses of CA (2.22±0.33 vs. 1.60±0.24; p=0.00001) and damage to the proximal parts of CA (p=0.0001).
Conclusions. The complication of the course of ACS by the development of the first episode of atrial fibrillation is more common in patients with angiographically intact coronary vessels, under condition of single-vessel atherosclerotic lesions of CA and involvement of the left CA in the atherosclerotic process. In patients with ACS and AF emerging for the first time, the level of NT-proBNP is higher compared to the group of patients without AF and to the group of patients with AF preceding the development of ACS, especially in patients with single-vessel CA damage.

Article Details


acute coronary syndrome, atrial fibrillation, atherosclerotic lesion of coronary arteries, brain natriuretic peptide, NT-proBNP


Belyayeva LE. Pathophysiology of arrhythmias: study guide.Vitebsk, VGMU. 2010.51p. (in Russ.).

Lang TA, Sesik M. How to describe statistics in medicine; per. from English by ed. V.P. Leonov. M.: Prakticheskaya meditsina, 2011.480p. (in Russ.).

Lapach SN, Chubenko AV, Babich PN. Statistical methods in biomedical research using Excel. K.: Morion, 2001.408p. (in Russ.).

Rebrova OYu. Statistical analysis of medical data. Application software package Statistica M.: MediaSfera, 2006.312p. (in Russ.).

Unifikovy klіnichny protocol of the externally, primary, secondary (medical) and therapeutic (high-specific) medicament of the medial reablation “Gastry coronary syndrome of the primary segment ST”.

Mandate of the Ministry of Health of Ukraine №455 (02.07.2014) (in Ukr.).

The main protocol of the primary protocol, of the primary, secondary (therapeutic) and the therapeutic medicaments of the secondary medicament, “Gastry coronary syndrome without ST segment segment” 2015 (in Ukr).

Benjamin E, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi C, Muntner P, Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation 2018; 137(12):e67–e492

Braga GC, Ramos V, Vieira C, Martins J, Ribeiro S, Gaspar A, Salgado A, Azevedo P, Pereira AM, Magalhães S, Correia A. New-onset atrial fibrillation during acute coronary syndromes: predictors and prognosis. Revista Portuguesa de Cardiologia. 2014 May;33(5):281–7. Epub 2014 Jun 13 (in Eng).

Chao TF, Huang YC, Liu CJ, Chen SJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chen TJ, Hsieh MH, Lip GY, Chen SA. Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study. Important because it used a large national health database of people with low CHA2DS2-VASc scores and showed that in similar persons there was an increased risk of MI. Heart Rhythm 2014;11(11):1941–7.

Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ.. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014;129(8):837–47.

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal 2018 Jan 7;39(2):119-177.

January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; ACC/AHA Task Force Members.January CT. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Journal of American College Cardiology. 2014;64(21):e1–76.

Kea B, Alligood T, Manning V, Raitt M. A Review of the Relationship of Atrial Fibrillation and Acute Coronary Syndrome. Current Emergency and Hospital Medicine Reports. 2016;4(3):107-118.

Marijon E1, Le Heuzey JY, Connolly S, Yang S, Pogue J, Brueckmann M, Eikelboom J, Themeles E, Ezekowitz M, Wallentin L, Yusuf S; RE-LY Investigators. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study. Circulation 2013;128(20):2192–201

McManus DD, Huang W, Domakonda KV, Ward J, Saczysnki JS, Gore JM, Goldberg RJ. Trends in atrial fibrillation in patients hospitalized with an acute coronary syndrome. The American Journal of Medicine 2012;125(11):1076-84.

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 2016;133(4):e38–e360.

Radwan H, Selem A, Ghazal K. Value of N-terminal pro brain natriuretic peptide in predicting prognosis and severity of coronary artery disease in acute coronary syndrome. Journal of the Saudi Heart Association. 2014;26(4):192-8.

Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S; ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal 2016;37(3):267–315.

Soliman, E. Z., Safford, M. M., Muntner, P., Khodneva, Y., Dawood, F. Z., Zakai, N. A., Thacker, E. L., Judd, S., Howard, V. J., Howard, G., Herrington, D. M., Cushman, M. Atrial fibrillation and the risk of myocardial infarction. JAMA internal medicine 2014; 174(1):107–14 (in Eng.).

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). Journal of American College Cardiology 2018;30,72(18):2231-2264.